Rockies Venture Club
Orbit Genomics’ OrbiSeq platform is transforming how we diagnose, treat and prevent complex diseases including cancer, heart and neurological diseases. Orbit's proprietary OrbiSeq platform analyzes novel markers, microsatellites, that uniquely reflect both inherited risk and risk acquired from lifestyle and environmental exposures. Their first product addresses lung cancer however the technology can be used to identify a variety of therapeutic targets.
Company Long-Form Pitch & Q&A w/ Investors (40 Minutes)
Product Demo (10 Minutes)
Outstanding Questions w/ Company (10 minutes)
Optional - Investor Only Discussion (30 Minutes)
Time: 10:00am to 11:30am MT